Moreover, we generated HDACis-resistant cells (HDACis-R cells) by treating HA22T cell line with apicidin, a novel HDAC-inhibitor, and investigated the molecular mechanisms of developing resistance in liver cancer cells [10–12]. This evidence concerns the gene HDAC9 and liver cancer.